SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-030228
Filing Date
2023-11-03
Accepted
2023-11-03 16:30:16
Documents
14
Period of Report
2023-11-02
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20231102c_8k.htm   iXBRL 8-K 24723
6 mbrx20231102c_8kimg001.jpg GRAPHIC 3372
  Complete submission text file 0001437749-23-030228.txt   165572

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20231102.xsd EX-101.SCH 3409
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20231102_def.xml EX-101.DEF 11424
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20231102_lab.xml EX-101.LAB 15310
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20231102_pre.xml EX-101.PRE 11584
8 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20231102c_8k_htm.xml XML 2560
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671997 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 231376813
SIC: 2834 Pharmaceutical Preparations